Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
2.
Perfusion ; : 2676591241264119, 2024 Jun 20.
Artículo en Inglés | MEDLINE | ID: mdl-38900997

RESUMEN

This technical report describes the successful transition from dual lumen, single site veno-venous extracorporeal membrane oxygenation ((dl)V-V ECMO) to single lumen, dual site veno-pulmonary (V-P) ECMO, and subsequently to dual lumen, single site (dl)V-P ECMO involving temporary placement of two cannulas in the main pulmonary artery. No complications were observed during these transitions. This technique could address concerns related to cannula exchanges in VP ECMO. However, caution is warranted and constant monitoring of cannula position using real-time imaging is required when using this technique due to the risk profile.

3.
ASAIO J ; 2024 Jun 25.
Artículo en Inglés | MEDLINE | ID: mdl-38913958

RESUMEN

Venopulmonary (VP) extracorporeal membrane oxygenation (ECMO) is a mode capable of supporting both pulmonary and right ventricular (RV) functions. Weaning patients from VP ECMO requires careful assessment of both RV and respiratory system recovery, which may occur at different rates. The weaning strategy described herein begins with weaning of respiratory ECMO support, followed by discontinuation of RV support. We also discuss situations in which the standard weaning strategy may require modification.

5.
ASAIO J ; 70(9): e123-e128, 2024 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-38768563

RESUMEN

This review highlights advancements in extracorporeal life support (ECLS), emphasizing the critical role of standardized terminology, particularly for extracorporeal membrane oxygenation (ECMO) in treating right ventricular and respiratory failure. Advocating for the adoption of the Extracorporeal Life Support Organization (ELSO) Maastricht Treaty for ECLS Nomenclature guidelines, it aims to resolve communication barriers in the ECMO field. Focusing on venopulmonary (VP) ECMO utilizing central pulmonary artery (PA) access, this review details surgical approaches and introduces a terminology guide to support effective knowledge exchange and advancements in patient care.


Asunto(s)
Oxigenación por Membrana Extracorpórea , Terminología como Asunto , Oxigenación por Membrana Extracorpórea/métodos , Humanos , Insuficiencia Respiratoria/terapia , Arteria Pulmonar
7.
Int J Artif Organs ; 47(1): 35-40, 2024 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-38053302

RESUMEN

INTRODUCTION: Diabetic ketoacidosis (DKA) is a common clinical problem. When patients develop severe shock and/or respiratory failure, extracorporeal membrane oxygenation (ECMO) may be considered. This case series describes the clinical presentation and outcomes of patients with DKA supported with ECMO. METHODS: We conducted a retrospective and anonymized review of 15 patients with DKA who required ECMO at our institution. Demographic and ECMO-specific data were collected. Additional variables include ICU length of stay (LOS), acute kidney injury and use of continuous renal replacement therapy, disposition, and mortality. RESULTS: All ECMO cannulations were performed by an intensivist using peripheral vascular access. The majority of patients were female (73%) with a median age of 27 (IQR = 21.5-45) years. A diagnosis of diabetes mellitus (DM) prior to ECMO was present in 11 (73%) patients. Venoarterial ECMO was the initial mode used in 11 (73%) patients. The median duration of ECMO support was 7 (IQR = 6-14) days. The median ICU LOS was 12 (IQR = 8.5-20.5) days, and the median hospital LOS was 21 (IQR = 11-36.5) days. Eight patients had cardiac arrest and underwent extracorporeal cardiopulmonary resuscitation (ECPR) of which 4 (50%) patients survived to discharge. Overall, 10 (66.7%) patients were successfully weaned from ECMO and survived to discharge. CONCLUSION: This is the largest case series regarding the use of ECMO for patients with refractory shock, cardiac arrest, or respiratory failure related to DKA. The findings suggest that ECMO is a viable support option for managing these patients and has excellent outcomes, including patients with cardiac arrest.


Asunto(s)
Reanimación Cardiopulmonar , Diabetes Mellitus , Cetoacidosis Diabética , Oxigenación por Membrana Extracorpórea , Paro Cardíaco , Insuficiencia Respiratoria , Humanos , Masculino , Femenino , Adulto Joven , Adulto , Persona de Mediana Edad , Oxigenación por Membrana Extracorpórea/efectos adversos , Cetoacidosis Diabética/complicaciones , Cetoacidosis Diabética/terapia , Estudios Retrospectivos , Paro Cardíaco/etiología , Paro Cardíaco/terapia , Insuficiencia Respiratoria/etiología , Insuficiencia Respiratoria/terapia , Resultado del Tratamiento , Diabetes Mellitus/etiología
8.
Perfusion ; : 2676591231210457, 2023 Nov 06.
Artículo en Inglés | MEDLINE | ID: mdl-37930875

RESUMEN

The rising application of extracorporeal membrane oxygenation (ECMO) has emphasized the need for consistent and standardized terminology, especially concerning peripheral percutaneous cannulation of the pulmonary artery (PPC-PA). The Extracorporeal Life Support Organization (ELSO) Nomenclature Task Force produced the ELSO Maastricht Treaty for extracorporeal life support (ECLS) Nomenclature to address this challenge. However, adherence to nomenclature recommendations has been poor in publications describing PPC-PA. We aim to describe common nomenclature errors and provide a user-guide for abbreviations that can be used by authors, reviewers, and journal staff to ensure properadherence to standardized nomenclature in publications describing PPC-PA.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...